{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:29:08Z","timestamp":1771036148952,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03196-6","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T06:02:55Z","timestamp":1719468175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hidradenitis suppurativa in patients with trisomy 13: a scoping review"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2771-266X","authenticated-orcid":false,"given":"Shanti","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-6621","authenticated-orcid":false,"given":"Dea","family":"Metko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9288-1121","authenticated-orcid":false,"given":"Cathryn","family":"Sibbald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"4","key":"3196_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jamadermatol.2020.5435","volume":"157","author":"C Liy-Wong","year":"2021","unstructured":"Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G (2021) Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients. JAMA Dermatology 157(4):385\u2013391","journal-title":"JAMA Dermatology"},{"issue":"1","key":"3196_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1542\/neo.24-1-e51","volume":"24","author":"RS Hu","year":"2023","unstructured":"Hu RS, Heffernan J, Sims J, Wojcik MH (2023) Trisomy 13: survival beyond the NICU. Neoreviews 24(1):51\u201356. https:\/\/doi.org\/10.1542\/neo.24-1-e51PMID: 36587011; PMCID: PMC10184504","journal-title":"Neoreviews"},{"issue":"12","key":"3196_CR3","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/ajmg.a.61365","volume":"179","author":"N Goel","year":"2019","unstructured":"Goel N, Morris JK, Tucker D, de Walle HE, Bakker MK, Kancherla V, Marengo L, Canfield MA, Kallen K, Lelong N, Camelo JL (2019) Trisomy 13 and 18\u2014Prevalence and mortality\u2014A multi-registry population based analysis. Am J Med Genet Part A 179(12):2382\u20132392","journal-title":"Am J Med Genet Part A"},{"issue":"3","key":"3196_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/pde.14949","volume":"39","author":"E Keyes","year":"2022","unstructured":"Keyes E, Larijani M, Castelo-Soccio L, Treat JR (2022) Severe recalcitrant hidradenitis suppurativa in a 2\u2010year\u2010old boy with partial trisomy 13. Pediatr Dermatol 39(3):491\u2013493","journal-title":"Pediatr Dermatol"},{"issue":"Supplement 1","key":"3196_CR5","first-page":"S48","volume":"36","author":"N Sigg","year":"2019","unstructured":"Sigg N, Benhard NB, Barbarot S, Martin L (2019) Acneiform lesions associated with trisomy 13. Two cases (poster presentations). Pediatr Dermatol 36(Supplement 1):S48","journal-title":"Pediatr Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03196-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03196-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:36:27Z","timestamp":1725914187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03196-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3196"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03196-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Dr. Cathryn Sibbald has received honoraria from Abbvie, Leo, Pfizer, Miravo, Novartis, UCB, Sanofi\/Regeneron unrelated to this work. Shanti Mehta and Dea Metko have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}